Novel Oral AntiCoagulants Market

List of Tables
Table 1. Novel Oral AntiCoagulants (NOAC) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Novel Oral AntiCoagulants (NOAC) Market Trends
Table 3. Novel Oral AntiCoagulants (NOAC) Market Drivers
Table 4. Novel Oral AntiCoagulants (NOAC) Market Challenges
Table 5. Novel Oral AntiCoagulants (NOAC) Market Restraints
Table 6. Global Novel Oral AntiCoagulants (NOAC) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Novel Oral AntiCoagulants (NOAC) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Novel Oral AntiCoagulants (NOAC) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Novel Oral AntiCoagulants (NOAC) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Novel Oral AntiCoagulants (NOAC) Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Novel Oral AntiCoagulants (NOAC) Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Novel Oral AntiCoagulants (NOAC) Revenue Share by Manufacturer, 2017-2022
Table 13. Global Novel Oral AntiCoagulants (NOAC) Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Novel Oral AntiCoagulants (NOAC) Sales Share by Manufacturer, 2017-2022
Table 15. Global Novel Oral AntiCoagulants (NOAC) Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Novel Oral AntiCoagulants (NOAC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Novel Oral AntiCoagulants (NOAC) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Oral AntiCoagulants (NOAC) as of 2021)
Table 18. Top Players of Novel Oral AntiCoagulants (NOAC) in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Novel Oral AntiCoagulants (NOAC) Product Type
Table 20. Date of International Manufacturers Enter into Novel Oral AntiCoagulants (NOAC) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Novel Oral AntiCoagulants (NOAC) Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Novel Oral AntiCoagulants (NOAC) Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Novel Oral AntiCoagulants (NOAC) Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Novel Oral AntiCoagulants (NOAC) Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Novel Oral AntiCoagulants (NOAC) Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Novel Oral AntiCoagulants (NOAC) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Novel Oral AntiCoagulants (NOAC) Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Novel Oral AntiCoagulants (NOAC) Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Novel Oral AntiCoagulants (NOAC) Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Novel Oral AntiCoagulants (NOAC) Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Novel Oral AntiCoagulants (NOAC) Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Novel Oral AntiCoagulants (NOAC) Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Novel Oral AntiCoagulants (NOAC) Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Novel Oral AntiCoagulants (NOAC) Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Novel Oral AntiCoagulants (NOAC) Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Novel Oral AntiCoagulants (NOAC) Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Novel Oral AntiCoagulants (NOAC) Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Novel Oral AntiCoagulants (NOAC) Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Novel Oral AntiCoagulants (NOAC) Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Novel Oral AntiCoagulants (NOAC) Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Johnson & Johnson Corporation Information
Table 43. Johnson & Johnson Description and Business Overview
Table 44. Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Product
Table 46. Johnson & Johnson Recent Development
Table 47. Bristol-Myers Squibb Corporation Information
Table 48. Bristol-Myers Squibb Description and Business Overview
Table 49. Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Bristol-Myers Squibb Product
Table 51. Bristol-Myers Squibb Recent Development
Table 52. Boehringer Ingelheim Corporation Information
Table 53. Boehringer Ingelheim Description and Business Overview
Table 54. Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Boehringer Ingelheim Product
Table 56. Boehringer Ingelheim Recent Development
Table 57. Sanofi Corporation Information
Table 58. Sanofi Description and Business Overview
Table 59. Sanofi Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Sanofi Product
Table 61. Sanofi Recent Development
Table 62. Daiichi Sankyo Corporation Information
Table 63. Daiichi Sankyo Description and Business Overview
Table 64. Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Daiichi Sankyo Product
Table 66. Daiichi Sankyo Recent Development
Table 67. Armatheon Corporation Information
Table 68. Armatheon Description and Business Overview
Table 69. Armatheon Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Armatheon Product
Table 71. Armatheon Recent Development
Table 72. Aspen Corporation Information
Table 73. Aspen Description and Business Overview
Table 74. Aspen Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Aspen Product
Table 76. Aspen Recent Development
Table 77. AstraZeneca Corporation Information
Table 78. AstraZeneca Description and Business Overview
Table 79. AstraZeneca Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. AstraZeneca Product
Table 81. AstraZeneca Recent Development
Table 82. Bayer Corporation Information
Table 83. Bayer Description and Business Overview
Table 84. Bayer Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Bayer Product
Table 86. Bayer Recent Development
Table 87. Cellceutix Corporation Information
Table 88. Cellceutix Description and Business Overview
Table 89. Cellceutix Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Cellceutix Product
Table 91. Cellceutix Recent Development
Table 92. Cosmo Pharmaceuticals Corporation Information
Table 93. Cosmo Pharmaceuticals Description and Business Overview
Table 94. Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. Cosmo Pharmaceuticals Product
Table 96. Cosmo Pharmaceuticals Recent Development
Table 97. CSL Behring Corporation Information
Table 98. CSL Behring Description and Business Overview
Table 99. CSL Behring Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. CSL Behring Product
Table 101. CSL Behring Recent Development
Table 102. Eisai Corporation Information
Table 103. Eisai Description and Business Overview
Table 104. Eisai Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 105. Eisai Product
Table 106. Eisai Recent Development
Table 107. GSK Corporation Information
Table 108. GSK Description and Business Overview
Table 109. GSK Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. GSK Product
Table 111. GSK Recent Development
Table 112. Marathon Pharmaceuticals Corporation Information
Table 113. Marathon Pharmaceuticals Description and Business Overview
Table 114. Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Marathon Pharmaceuticals Product
Table 116. Marathon Pharmaceuticals Recent Development
Table 117. Ockham Biotech Corporation Information
Table 118. Ockham Biotech Description and Business Overview
Table 119. Ockham Biotech Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 120. Ockham Biotech Product
Table 121. Ockham Biotech Recent Development
Table 122. Perosphere Corporation Information
Table 123. Perosphere Description and Business Overview
Table 124. Perosphere Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 125. Perosphere Product
Table 126. Perosphere Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Novel Oral AntiCoagulants (NOAC) Customers List
Table 130. Novel Oral AntiCoagulants (NOAC) Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Novel Oral AntiCoagulants (NOAC) Product Picture
Figure 2. Global Novel Oral AntiCoagulants (NOAC) Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Novel Oral AntiCoagulants (NOAC) Market Size 2017-2028 (US$ Million)
Figure 4. Global Novel Oral AntiCoagulants (NOAC) Sales 2017-2028 (K Pcs)
Figure 5. United States Novel Oral AntiCoagulants (NOAC) Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Novel Oral AntiCoagulants (NOAC) Market Size 2017-2028 (US$ Million)
Figure 7. United States Novel Oral AntiCoagulants (NOAC) Sales 2017-2028 (K Pcs)
Figure 8. United States Novel Oral AntiCoagulants (NOAC) Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Novel Oral AntiCoagulants (NOAC) Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Novel Oral AntiCoagulants (NOAC) Report Years Considered
Figure 11. Product Picture of Direct Thrombin Inhibitors
Figure 12. Product Picture of Direct Factor Xa Inhibitors
Figure 13. Global Novel Oral AntiCoagulants (NOAC) Market Share by Type in 2022 & 2028
Figure 14. Global Novel Oral AntiCoagulants (NOAC) Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Novel Oral AntiCoagulants (NOAC) Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Novel Oral AntiCoagulants (NOAC) Sales by Type (2017-2028) & (K Pcs)
Figure 17. Global Novel Oral AntiCoagulants (NOAC) Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Novel Oral AntiCoagulants (NOAC) Price by Type (2017-2028) & (USD/Pcs)
Figure 19. United States Novel Oral AntiCoagulants (NOAC) Market Share by Type in 2022 & 2028
Figure 20. United States Novel Oral AntiCoagulants (NOAC) Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Novel Oral AntiCoagulants (NOAC) Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Novel Oral AntiCoagulants (NOAC) Sales by Type (2017-2028) & (K Pcs)
Figure 23. United States Novel Oral AntiCoagulants (NOAC) Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Novel Oral AntiCoagulants (NOAC) Price by Type (2017-2028) & (USD/Pcs)
Figure 25. Product Picture of Deep Vein Thrombosis (DVT)
Figure 26. Product Picture of Pulmonary Embolism
Figure 27. Product Picture of Acute Coronary Syndrome
Figure 28. Product Picture of Hemodialysis
Figure 29. Product Picture of Others
Figure 30. Global Novel Oral AntiCoagulants (NOAC) Market Share by Application in 2022 & 2028
Figure 31. Global Novel Oral AntiCoagulants (NOAC) Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Novel Oral AntiCoagulants (NOAC) Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Novel Oral AntiCoagulants (NOAC) Sales by Application (2017-2028) & (K Pcs)
Figure 34. Global Novel Oral AntiCoagulants (NOAC) Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Novel Oral AntiCoagulants (NOAC) Price by Application (2017-2028) & (USD/Pcs)
Figure 36. United States Novel Oral AntiCoagulants (NOAC) Market Share by Application in 2022 & 2028
Figure 37. United States Novel Oral AntiCoagulants (NOAC) Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Novel Oral AntiCoagulants (NOAC) Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Novel Oral AntiCoagulants (NOAC) Sales by Application (2017-2028) & (K Pcs)
Figure 40. United States Novel Oral AntiCoagulants (NOAC) Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Novel Oral AntiCoagulants (NOAC) Price by Application (2017-2028) & (USD/Pcs)
Figure 42. North America Novel Oral AntiCoagulants (NOAC) Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 43. North America Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Novel Oral AntiCoagulants (NOAC) Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 47. Europe Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Novel Oral AntiCoagulants (NOAC) Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 54. Asia-Pacific Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. China Taiwan Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Novel Oral AntiCoagulants (NOAC) Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 65. Latin America Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 70. Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. UAE Novel Oral AntiCoagulants (NOAC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Novel Oral AntiCoagulants (NOAC) Value Chain
Figure 75. Novel Oral AntiCoagulants (NOAC) Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed